Health Care Maintenance of HIV Infected Women at a Tertiary Care Center
American Journal of Internal Medicine
Volume 4, Issue 6, November 2016, Pages: 101-106
Received: Oct. 1, 2016; Accepted: Oct. 26, 2016; Published: Nov. 19, 2016
Views 2658      Downloads 78
Authors
Mohamed Ali Elkarouri, Department of Medicine, Section of Infectious Diseases, Security Forces Hospital, Riyadh, Saudi Arabia
Muneerah Mohammed Albugami, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Magid A. Halim Mohamed, Department of Medicine, Section of Infectious Diseases, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Munirah Abdulrahman Bin Dahham, Department of Medicine, Section of Infectious Diseases, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Yasmin Ahmed Al Twaijri, Research Centre, Department of Biostatistics, Epidemiology and Scientific Computing, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Article Tools
Follow on us
Abstract
Introduction: HIV care should change from HIV focused approach to one which addresses chronic diseases, counseling, screening of non-AIDS related malignancies and immunization. Our objectives are to review standard of health maintenance services (screening, counselling and immunization) among HIV infected women and to find the prevalence of co-morbid conditions. Methodology: Retrospective cohort study to review HIV infected women in HIV clinic at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (KFSH&RC) from January 2008 to December 2012. Results: Among 103 HIV infected women, dyslipidemia accounts for 31.07%, hypertension 16.5%, diabetes mellitus 14.6%, patients who have more than two co-morbid conditions were 24.5%. Vitamin D level was requested for 93.20%. HIV viral load wasn’t detectable in 63.11% and antiretroviral therapy was prescribed for 99.02%. The median latest CD4 lymphocyte count was 725 cells/ µmol. Tuberculin screening test (TST) was done for 5.88%. Screening mammography and Pap smear were done for 37.25%, 13.73% respectively. Colorectal cancer screening was not done in 96.11%. Bone densitometry screening was done for 36.36%. Mental status evaluation was performed for 63.73%. Influenza, pneumococcal, hepatitis B virus and Human Papilloma Virus (HPV) vaccination were received by 93.20%, 49.51%, 17.47% and 1.94% respectively. Counseling for condom use was provided to 64.79% and hormonal contraception/obstetrics referral were done for 49.02%. Conclusion: Our HIV clinic is providing a standard HIV focused patient care. Screening for tuberculosis, malignancies, counseling for hormonal contraception and immunization were deficient. There is high prevalence of cardiovascular risk factors among our patients. There is an urgent need to improve delivery of preventive health care to HIV-infected women.
Keywords
HIV Infected Women, Health Maintenance, Preventive Care
To cite this article
Mohamed Ali Elkarouri, Muneerah Mohammed Albugami, Magid A. Halim Mohamed, Munirah Abdulrahman Bin Dahham, Yasmin Ahmed Al Twaijri, Health Care Maintenance of HIV Infected Women at a Tertiary Care Center, American Journal of Internal Medicine. Vol. 4, No. 6, 2016, pp. 101-106. doi: 10.11648/j.ajim.20160406.12
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Chu C, Selwyn PA. An epidemic in evolution: the need for new models of HIV care in the chronic disease era. J Urban Health. 2011 Jun; 88 (3): 556-66.
[2]
Fultz SL, Goulet JL, Weissman S, Rimland D, Leaf D, Gibert C, Rodriguez-Barradas MC, Justice AC. Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis. 2005 Sep 1; 41 (5): 738-43.
[3]
Sheth AN, Moore RD, Gebo KA. Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic. AIDS Patient Care STDS. 2006 May; 20 (5): 318-25.
[4]
Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA; Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jan; 58 (1): e1-34.
[5]
Momplaisir F, Mounzer K, Long JA. Preventive cancer screening practices in HIV-positive patients. AIDS Care. 2014 Jan; 26 (1): 87-94.
[6]
Simonsen SE, Kepka D, Thompson J, Warner EL, Snyder M, Ries KM. Preventive health care among HIV positive women in a Utah HIV/AIDS clinic: a retrospective cohort study. BMC Womens Health. 2014 Mar 4; 14 (1): 37.
[7]
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007 Jul 7; 370 (9581): 59-67.
[8]
Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States. J Womens Health (Larchmt). 2010 Apr; 19 (4): 709-12.
[9]
Latif N, Rana F, Guthrie T. Breast cancer and HIV in the era of highly active antiretroviral therapy: two case reports and review of the literature. Breast J. 2011 Jan-Feb; 17 (1): 87-92
[10]
Wasserberg N, Nunoo-Mensah JW, Gonzalez-Ruiz C, Beart RW Jr, Kaiser AM. Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis. 2007 Oct; 22 (10): 1217-21.
[11]
Reinhold JP, Moon M, Tenner CT, Poles MA, Bini EJ. Colorectal cancer screening in HIVinfected patients 50 years of age and older: missedopportunities for prevention. Am J Gastroenterol. 2005 Aug; 100 (8): 1805-12.
[12]
Christopher Chapman, David M. Aboulafia, Bruce J. Dezube, Liron Pantanowitz. Human Immunodeficiency Virus–Associated Adenocarcinoma of the Colon: Clinicopathologic Findings and Outcome. Clinical Colorectal Cancer. October 2009 Volume 8, Issue 4, Pages 215-219
[13]
Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS. 2007 Mar 12; 21 (5): 617-23.
[14]
McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010 Oct 15; 51 (8): 937-46.
[15]
Elsammak MY, Al-Wossaibi AA, Al-Howeish A, Alsaeed J. High prevalence of vitamin D deficiency in the sunny Eastern region of Saudi Arabia: a hospital-based study. East Mediterr Health J. 2011 Apr; 17 (4): 317-22.
[16]
Al-Turki HA, Sadat-Ali M, Al-Elq AH, Al-Mulhim FA, Al-Ali AK. 25-Hydoxyvitamin D levels among healthy Saudi Arabian women. Saudi Med J. 2008 Dec; 29 (12): 1765-8.
[17]
Adeyemi OM, Agniel D, French AL, Tien PC, Weber K, Glesby MJ, Villacres MC, Sharma A, Merenstein D, Golub ET, Meyer W, Cohen M. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune DeficSyndr. 2011 Jul 1; 57 (3): 197-204.
[18]
Fantry LE, Zhan M, Taylor GH, Sill AM, Flaws JA. Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient Care STDS. 2005 Nov; 19 (11): 703-11.
[19]
Ferreira CE, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Magalhães J. Menopause symptoms in women infected with HIV: prevalence and associated factors. Gynecol Endocrinol. 2007 Apr; 23 (4): 198-205.
[20]
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I; Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58 (3): 309-18.
[21]
Fultz SL, Goulet JL, Weissman S, Rimland D, Leaf D, Gibert C, Rodriguez-Barradas MC, Justice AC. Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis. 2005 Sep 1; 41 (5): 738-43.
[22]
Coplan PM, Nikas A, Japour A, Cormier K, Maradit-Kremers H, Lewis R, Xu Y, DiNubile MJ. Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors. AIDS Res Hum Retroviruses. 2003 Jun; 19 (6): 449-55.
[23]
Klein D, Hurley LB, Quesenberry CP Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune DeficSyndr. 2002 Aug 15; 30 (5): 471-7.
[24]
Writing Committee: N Friis-Moller, CA Sabin, R Weber, A d'ArminioMonforte, WM El-Sadr, P Reiss, R Thiebaut, L Morfeldt, S De Wit, C Pradier, G Calvo, MG Law, O Kirk, AN Phillips, JD Lundgren. Combination Antiretroviral Therapy and the Risk of Myocardial Infarction. The Data Collection o¬n Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. N Engl J Med. 2003; 349 (21); 1993-2003.
[25]
Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D; Clinical Epidemiology Group from the French Hospital Database. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003 Nov 21; 17 (17): 2479-86.
[26]
Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007 Jul; 92 (7): 2506-12.
[27]
Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003 Feb 20; 348 (8): 702-10
[28]
El Bcheraoui C, Memish ZA, Tuffaha M, Daoud F, Robinson M, Jaber S, Mikhitarian S, Al Saeedi M, AlMazroa MA, Mokdad AH, Al Rabeeah AA. Hypertension and its associated risk factors in the kingdom of saudi arabia, 2013: a national survey. Int J Hypertens. 2014; 2014: 564679.
[29]
Basulaiman M, El Bcheraoui C, Tuffaha M, Robinson M, Daoud F, Jaber S, Mikhitarian S, Wilson S, Memish ZA, Al Saeedi M, AlMazroa MA, Mokdad AH. Hypercholesterolemia and its associated risk factors-Kingdom of Saudi Arabia, 2013. Ann Epidemiol. 2014 Nov; 24 (11): 801-8.
[30]
Memish ZA, El Bcheraoui C, Tuffaha M, Robinson M, Daoud F, Jaber S, Mikhitarian S, Al Saeedi M, AlMazroa MA, Mokdad AH, Al Rabeeah AA. Obesity and associated factors--Kingdom of Saudi Arabia, 2013. Prev Chronic Dis. 2014 Oct 9; 11: E174.
[31]
Deeken JF, Tjen-A-Looi A, Rudek MA, Okuliar C, Young M, Little RF, Dezube BJ. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012 Nov; 55 (9): 1228-35.
[32]
Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med. 1997 Jan 15; 126 (2): 123-32.
[33]
Gerald H. Mazurek, MD, John Jereb, MD, Andrew Vernon, MD, Phillip LoBue, MD, Stefan Goldberg, MD, Kenneth Castro, MD. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep 2010; 59: 1–25.
[34]
Alhuraiji A, Alaraj A, Alghamdi S, Alrbiaan A, Alrajhi AA. Viral hepatitis B and C in HIV-infected patients in Saudi Arabia. Ann Saudi Med. 2014 May-Jun; 34 (3): 207-10
[35]
Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis. 2003 Aug 15; 188 (4): 571-7.
[36]
Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE. HIV infection and bone mineral density in middle-aged women. Clin Infect Dis. 2006 Apr 1; 42 (7): 1014-20.
[37]
Yin M, Dobkin J, Brudney K, Becker C, Zadel JL, Manandhar M, Addesso V, Shane E. Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporos Int. 2005 Nov; 16 (11): 1345-52.
[38]
Yin MT, McMahon DJ, Ferris DC, Zhang CA, Shu A, Staron R, Colon I, Laurence J, Dobkin JF, Hammer SM, Shane E. Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women. J ClinEndocrinol Metab. 2010 Feb; 95 (2): 620-9.
[39]
Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J ClinEndocrinolMetab. 2008 Sep; 93 (9): 3499-504.
[40]
Komiti A, Judd F, Grech P, Mijch A, Hoy J, Williams B, Street A, Lloyd JH. Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Aust N Z J Psychiatry. 2003 Feb; 37 (1): 70-7.
[41]
Jeannette R. Ickovics, Merle E. Hamburger, David Vlahov, Ellie E. Schoenbaum, Paula Schuman, Robert J. Boland, Janet Moore. Mortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive Women. Longitudinal Analysis From the HIV Epidemiology Research Study. JAMA. 2001; 285 (11): 1466-1474.
[42]
Morrison MF, Petitto JM, Ten Have T, Gettes DR, Chiappini MS, Weber AL, Brinker-Spence P, Bauer RM, Douglas SD, Evans DL. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002 May; 159 (5): 789-96.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186